Enanta Pharmaceuticals Files 8-K
Ticker: ENTA · Form: 8-K · Filed: May 6, 2024 · CIK: 1177648
| Field | Detail |
|---|---|
| Company | Enanta Pharmaceuticals Inc (ENTA) |
| Form Type | 8-K |
| Filed Date | May 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting
TL;DR
Enanta Pharma filed an 8-K on May 6th, reporting financial updates.
AI Summary
Enanta Pharmaceuticals, Inc. filed an 8-K on May 6, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signifies a formal update from Enanta Pharmaceuticals to the SEC regarding its financial status and operations, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure and does not inherently present new risks based on the provided text.
Key Players & Entities
- Enanta Pharmaceuticals, Inc. (company) — Registrant
- May 06, 2024 (date) — Date of earliest event reported
- 0000950170-24-053532 (filing_id) — Accession Number
- 500 Arsenal Street, Watertown, Massachusetts 02472 (address) — Principal Executive Offices
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text for the 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not include the specific financial figures or operational details within this excerpt.
When was this 8-K filing submitted to the SEC?
The filing was submitted on May 6, 2024, as indicated by the 'Date of Report (Date of earliest event reported)'.
What is the company's principal executive office address?
The company's principal executive offices are located at 500 Arsenal Street, Watertown, Massachusetts 02472.
What is the Commission File Number for Enanta Pharmaceuticals, Inc.?
The Commission File Number for Enanta Pharmaceuticals, Inc. is 001-35839.
What is the Standard Industrial Classification code for Enanta Pharmaceuticals, Inc.?
The Standard Industrial Classification code for Enanta Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 441 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2024-05-06 16:05:14
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share ENTA Nasdaq Global Select
Filing Documents
- enta-20240506.htm (8-K) — 37KB
- enta-ex99_1.htm (EX-99.1) — 207KB
- img152620751_0.jpg (GRAPHIC) — 16KB
- 0000950170-24-053532.txt ( ) — 391KB
- enta-20240506.xsd (EX-101.SCH) — 24KB
- enta-20240506_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On May 6, 2024, Enanta Pharmaceuticals, Inc. announced via press release its results for the fiscal quarter ended March 31, 2024. A copy of Enanta's press release is hereby furnished to the Commission and incorporated by reference herein as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release of Enanta Pharmaceuticals, Inc. dated May 6, 2024, reporting Enanta's financial results for the fiscal quarter ended March 31, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ENANTA PHARMACEUTICALS, INC. Date: May 6, 2024 By: /s/ Paul J. Mellett Paul J. Mellett Chief Financial and Administrative Officer